214 related articles for article (PubMed ID: 25004249)
1. Uncoupling of secretion from growth in some hormone secretory tissues.
Marx SJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4051-9. PubMed ID: 25004249
[TBL] [Abstract][Full Text] [Related]
2. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
Marx SJ
J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
[TBL] [Abstract][Full Text] [Related]
3. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.
Henquin JC; Nenquin M; Sempoux C; Guiot Y; Bellanné-Chantelot C; Otonkoski T; de Lonlay P; Nihoul-Fékété C; Rahier J
J Clin Invest; 2011 Oct; 121(10):3932-42. PubMed ID: 21968111
[TBL] [Abstract][Full Text] [Related]
4. Multiplicity of hormone-secreting tumors: common themes about cause, expression, and management.
Marx SJ
J Clin Endocrinol Metab; 2013 Aug; 98(8):3139-48. PubMed ID: 23771922
[TBL] [Abstract][Full Text] [Related]
5. Hereditary hormone excess: genes, molecular pathways, and syndromes.
Marx SJ; Simonds WF
Endocr Rev; 2005 Aug; 26(5):615-61. PubMed ID: 15632315
[TBL] [Abstract][Full Text] [Related]
6. Benign familial hypocalciuric hypercalcemia.
Varghese J; Rich T; Jimenez C
Endocr Pract; 2011; 17 Suppl 1():13-7. PubMed ID: 21478088
[TBL] [Abstract][Full Text] [Related]
7. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
Marx SJ; Lourenço DM
Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
[TBL] [Abstract][Full Text] [Related]
8. Familial benign hypercalcemia--from clinical description to molecular genetics.
Heath H
West J Med; 1994 Jun; 160(6):554-61. PubMed ID: 8053177
[TBL] [Abstract][Full Text] [Related]
9. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
Falchetti A; Gozzini A; Terranegra A; Soldati L; Vezzoli G; Leoncini G; Giusti F; Franceschelli F; Masi L; Tanini A; Cavalli L; Brandi ML
Eur J Endocrinol; 2012 May; 166(5):933-40. PubMed ID: 22315359
[TBL] [Abstract][Full Text] [Related]
10. [Familial hypocalciuric hypercalcemia: A case report].
Andrade Navarro MT; Pérez González E; Cantos Pastor V; Marín Patón M; Lara Ruiz A
Arch Argent Pediatr; 2018 Dec; 116(6):e757-e761. PubMed ID: 30457731
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-secreting tumors and the idea of the pseudoectopic hormone secretion in tumors.
Kurbel S; Kurbel B; Kovacić D; Sulava D; Krajina Z; Dmitrović B; Sokcević M
Med Hypotheses; 1999 Apr; 52(4):329-33. PubMed ID: 10465672
[TBL] [Abstract][Full Text] [Related]
13. [Hormonal interactions of parathormone and calcium metabolism].
Kovács L
Orv Hetil; 2003 Jan; 144(1):3-12. PubMed ID: 12635347
[TBL] [Abstract][Full Text] [Related]
14. Familial hypocalciuric hypercalcemia and related disorders.
Lee JY; Shoback DM
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):609-619. PubMed ID: 30449544
[TBL] [Abstract][Full Text] [Related]
15. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.
Banerjee I; Salomon-Estebanez M; Shah P; Nicholson J; Cosgrove KE; Dunne MJ
Diabet Med; 2019 Jan; 36(1):9-21. PubMed ID: 30246418
[TBL] [Abstract][Full Text] [Related]
16. Muscle function and quality of life are not impaired in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene (CASR).
Jakobsen NF; Rolighed L; Nissen PH; Mosekilde L; Rejnmark L
Eur J Endocrinol; 2013 Sep; 169(3):349-57. PubMed ID: 23764372
[TBL] [Abstract][Full Text] [Related]
17. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
Shinall MC; Dahir KM; Broome JT
Endocr Pract; 2013; 19(4):697-702. PubMed ID: 23425644
[TBL] [Abstract][Full Text] [Related]
18. A de novo CACNA1D missense mutation in a patient with congenital hyperinsulinism, primary hyperaldosteronism and hypotonia.
De Mingo Alemany MC; Mifsud Grau L; Moreno Macián F; Ferrer Lorente B; León Cariñena S
Channels (Austin); 2020 Dec; 14(1):175-180. PubMed ID: 32336187
[TBL] [Abstract][Full Text] [Related]
19. Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia.
Cecconi E; Bogazzi F; Cetani F; Grasso L; Marcocci C; Genovesi M; Procopio M; Gasperi M; Pinchera A; Ghigo E; Martino E
Clin Endocrinol (Oxf); 2003 Nov; 59(5):604-6. PubMed ID: 14616884
[TBL] [Abstract][Full Text] [Related]
20. Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1).
Dharmaraj P; Gorvin CM; Soni A; Nelhans ND; Olesen MK; Boon H; Cranston T; Thakker RV; Hannan FM
J Clin Endocrinol Metab; 2020 May; 105(5):1393-400. PubMed ID: 32150253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
